Expert opinion—management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors

Regardless of line of therapy, treatment goals in chronic phase chronic myeloid leukemia (CML) are: avoid progression to accelerated phase or blast crisis CML such that patients achieve a life expectancy comparable with that of the general population; avoid adverse events (AEs); and restore and main...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Leukemia
Egile Nagusiak: Hochhaus, Andreas, Breccia, Massimo, Saglio, Giuseppe, García-Gutiérrez, Valentín, Réa, Delphine, Janssen, Jeroen, Apperley, Jane
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2020
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7266739/
https://ncbi.nlm.nih.gov/pubmed/32366938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-020-0842-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak